What Researchers Did
Researchers investigated the antiviral effects of hyperbaric oxygen (HBO) therapy on HIV-infected plasma and peripheral blood mononuclear cells (PBMCs) using ex vivo and in vivo quantitative assays.
What They Found
The study found that hyperbaric oxygen therapy decreased HIV viral load in the infected cells. Additionally, few viruses entered uninfected PBMCs that had been exposed to HBO.
What This Means for Canadian Patients
This early research suggests a potential new avenue for HIV treatment, though further clinical trials are needed to confirm its efficacy and safety. If proven effective, HBO therapy could offer an additional therapeutic option for managing HIV infection in patients.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A key limitation of this study is the absence of specific quantitative data and the lack of large-scale human clinical trial results.